Aging
Navigate
Review|Volume 13, Issue 4|pp 6214—6227

Early diagnosis of lung cancer: which is the optimal choice?

Jing Ning1,2, Tao Ge1, Minlin Jiang1,2, Keyi Jia1,2, Lei Wang1, Wei Li1, Bin Chen1, Yu Liu1,2, Hao Wang1,2, Sha Zhao1, Yayi He1
  • 1Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai 200433, People’s Republic of China
  • 2Tongji University, Shanghai 200433, People’s Republic of China
Received: July 3, 2020Accepted: December 18, 2020Published: February 11, 2021

Copyright: © 2021 Ning et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

The prognosis of lung cancer patients with different clinical stages is significantly different. The 5-year survival of stage IA groups can exceed 90%, while patients with stage IV can be less than 10%. Therefore, early diagnosis is extremely important for lung cancer patients. This research focused on various diagnosis methods of early lung cancer, including imaging screening, bronchoscopy, and emerging potential liquid biopsies, as well as volatile organic compounds, autoantibodies, aiming to improve the early diagnosis rate and explore feasible and effective early diagnosis strategies.